Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in CAR T Cell Therapy for Relapsed/Refractory Lymphoma
NCT07042438Phase 2Recruiting
- Sponsor
- City of Hope
- Start
- Feb 2026
- Primary completion
- Jan 2029
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised trial of Fecal Microbiota Transplantation Capsule in B cell lymphoma (2 arms), sponsored by City of Hope. Primary endpoint: Changes in gut microbiome diversity (Shannon alpha diversity Index) at Day 0. Started Feb 2026; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT07042438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07042438.